11 July 2024

India can be Intelligence Capital of the World, says Nvidia’s Dhupar

Vishal Dhupar of Nvidia proposes India’s potential as a global intelligence hub, leveraging its technological and human resources. Source and citation: Our bureau, “India can be Intelligence Capital of the World, says Nvidia’s Dhupar.” Last Updated: Jul 11, 2024. TLDR For This Article: Nvidia’s South Asia MD, Vishal Dhupar, advocates for India’s evolution from a […]

India can be Intelligence Capital of the World, says Nvidia’s Dhupar Read More »

Capital Group Affiliate Sells Rs770.69 cr of Shares in Mankind Pharma via Block Deal

Exploring the recent block deal involving Capital Group’s sale of Mankind Pharma shares and its market implications. Source and citation: ET Bureau. “Capital Group Affiliate Sells Rs770.69 cr of Shares in Mankind Pharma via Block Deal.” ET Bureau, July 11, 2024. TLDR For This Article: Capital Group affiliate Hema Cipef (I) sold shares worth Rs770.69

Capital Group Affiliate Sells Rs770.69 cr of Shares in Mankind Pharma via Block Deal Read More »

SBI Mops Up ₹10k cr Via Infra Bonds; Canara, BoI Eye ₹15k cr

A deep dive into SBI’s ₹10k crore infrastructure bond issuance and its implications for the banking sector and investors. Source and citation: Our bureau, “SBI Mops Up ₹10k cr Via Infra Bonds; Canara, BoI Eye ₹15k cr.” Last Updated: Jul 11, 2024. TLDR For This Article: State Bank of India successfully raised ₹10,000 crore through

SBI Mops Up ₹10k cr Via Infra Bonds; Canara, BoI Eye ₹15k cr Read More »

SAT Orders Religare to Apply with Sebi for Open Offer by Burmans

Dissecting the SAT’s recent order for Religare to proceed with an open offer by the Burmans, examining its broader market implications. Source and citation: ET Bureau. “SAT Orders Religare to Apply with Sebi for Open Offer by Burmans.” ET Bureau, July 11, 2024. TLDR For This Article: The Securities Appellate Tribunal has instructed Religare Enterprises

SAT Orders Religare to Apply with Sebi for Open Offer by Burmans Read More »

Glenmark Pharma, Saldanha to Exit Life Sciences Arm, Sell 7.85% Stake

Analysing Glenmark Pharma’s decision to exit its Life Sciences arm by selling a 7.85% stake, and its impact on stakeholders. Source and citation: ET Bureau. “Glenmark Pharma, Saldanha to Exit Life Sciences Arm, Sell 7.85% Stake.” ET Bureau, July 11, 2024. TLDR For This Article: Glenmark Pharmaceuticals completes its exit from Glenmark Life Sciences by

Glenmark Pharma, Saldanha to Exit Life Sciences Arm, Sell 7.85% Stake Read More »

In Equity’s Indian Summer, IPOs and Investors Make Hay in 2024

Analysing the surge in Indian IPOs in 2024, their performance, and the implications for investors and industries. Source and citation: Mascarenhas, Rajesh. “In Equity’s Indian Summer, IPOs and Investors Make Hay in 2024.” ET Bureau, July 11, 2024. TLDR For This Article: The Indian IPO market in 2024 has seen significant activity with many offerings

In Equity’s Indian Summer, IPOs and Investors Make Hay in 2024 Read More »

TruAlt Bioenergy Bags ₹390-cr 1G Bioethanol Order from OMCs

Unpack TruAlt Bioenergy’s ₹390-crore bioethanol deal with major oil companies and its impact on the energy sector. Source and citation: ET Bureau. “TruAlt Bioenergy Bags ₹390-cr 1G Bioethanol Order from OMCs.” ET Bureau, July 11, 2024. TLDR For This Article: TruAlt Bioenergy has clinched a significant contract to supply first-generation bioethanol to leading Indian oil

TruAlt Bioenergy Bags ₹390-cr 1G Bioethanol Order from OMCs Read More »

RoC Slaps Penalty on HeroX, 2 Execs for Lapses in Beneficial Owner Rules

Explore the consequences of HeroX’s penalty for non-disclosure of significant beneficial owners on investors and related industries. Source and citation: Rajput, Rashmi. “RoC Slaps Penalty on HeroX, 2 Execs for Lapses in Beneficial Owner Rules.” ET Bureau, July 11, 2024. TLDR For This Article: HeroX and its executives faced penalties for failing to disclose their

RoC Slaps Penalty on HeroX, 2 Execs for Lapses in Beneficial Owner Rules Read More »

error: Content is protected !!
Scroll to Top
×